Evaluation of the Use of Trental and Vitamin E For Prophylaxis of Radiation Necrosis
Status:
Unknown status
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the use of Trental and Vitamin E can help
reduce the incidence of radiation necrosis (a lesion that usually occurs at the original
tumor site) after radiosurgery. These two drugs are commonly used to treat radiation necrosis
when it occurs but the hope is that these drugs can be used to prevent radiation necrosis
from ever occurring.
Phase:
Phase 2
Details
Lead Sponsor:
University of Cincinnati
Treatments:
alpha-Tocopherol Pentoxifylline Tocopherols Tocotrienols Vitamin E Vitamins